NASDAQ NMS - GLOBAL MARKET · QTTB
-1.91% · -$0.3100 · Vol 513.5K
Market closed · last close 4:00 PM ET · price as of 16:45:43 ET
Q32 Bio Inc

Q32 Bio Inc

Biotechnology
$15.89
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
QTTB
Q32 Bio Inc
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is QTTB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading QTTB catalysts
About Q32 Bio Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
22
Country
US

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$16.58
Day high
$16.58
Day low
$15.41
Previous close
$16.20
52W high
$21.38
-25.68% from high
52W low
$1.63
72% of range
Market cap
$464.3M
P/E
15.67×
EPS
$-2.3600
Beta
-1.13
Shares out
29.8M
Volume
513.5K
0.27× rel vol
Avg volume
1.9M
VWAP
$15.75
Price history computed in-house
1W
+1.34%
1M
+26.21%
3M
+195.90%
1Y
+874.85%
YTD
+378.61%
SMA 50 $13.87 · above
SMA 200 $6.77 · above
52W position 72%

QTTB overview

Veridion Score
65
4 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around QTTB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading QTTB Form 4 filings
Public disclosures

Congress activity in QTTB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for QTTB in the cached public ledger.

Federal contracts

QTTB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for QTTB in this window.
Lobbying spend

QTTB lobbying filings, year to date.

Registered lobbying filings matched to Q32 Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for QTTB in this window.
Loading news for QTTB
Analyst ratings
Sovereign unlock shows live analyst consensus for QTTB.
Options
Sovereign unlock shows live options positioning for QTTB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.